Antiretrovirals
Search result(s): 15
  •  All
  •  Article
  •  Assessment
  •  Book
  •  Chapter
  •  Collection
  •  Issue
  •  Journal
  •  Manual
  •  Series
  •  Staticpage
  •  Volume
Availability
  • Available for purchase
  • Open access
  • Complimentary
  • Purchased
  • Free
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
Article Year: 2021
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
Article Year: 2021
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
Article Year: 2021
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis
Article Year: 2021
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis
Article Year: 2021
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis
Article Year: 2021
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding
Article Year: 2021
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding
Article Year: 2021
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding
Article Year: 2021
An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore
An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore
Article Year: 2021
An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore
An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore
Article Year: 2021
An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore
An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore
Article Year: 2021
Immunization by exposure to live virus (SIV<sub>mne</sub>/HIV-2<sub>287</sub>) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
Article Year: 2021
Immunization by exposure to live virus (SIV<sub>mne</sub>/HIV-2<sub>287</sub>) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
Article Year: 2021
Immunization by exposure to live virus (SIV<sub>mne</sub>/HIV-2<sub>287</sub>) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
Article Year: 2021